This is a working overview of actin-binding motif, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-03-07. Anything still debated is marked as such rather than presented as settled.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.
Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | N-terminal fragment of thymosin beta-4 |
| Residue count | Seven | Sequence LKKTETQ |
| Approximate mass | 889 Da | Acetylated seven-residue peptide |
| Common synonyms | TB4 fragment, TB500 | Not identical to full-length TB4 |
| Reported activity | Actin binding | Observed mainly in cell-free systems |
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
=== Type I civilization methods === Large-scale application of fusion power: In terms of mass–energy equivalence, Type I implies the conversion of about 2 kg of matter to energy per second. An equivalent energy release could theoretically be achieved by fusing about 280 kg of hydrogen into helium per second, a rate roughly equivalent to 8.9×109 kg/year. One cubic kilometer of water contains about 1011 kg of hydrogen, and the Earth's oceans contain about 1.3×109 km3 of water, meaning that humans on Earth could sustain this rate of consumption over geological time scales, in terms of available hydrogen. Antimatter in large quantities would provide a mechanism to produce power on a scale several orders of magnitude beyond the current level of technology. In antimatter-matter collisions, all of the rest mass of the particles is converted to radiant energy. Their energy density (energy released per mass) is about four orders of magnitude greater than that from using nuclear fission, and about two orders of magnitude greater than the best possible yield from fusion. The reaction of 1 kg of antimatter with 1 kg of matter would produce 1.8×1017 J (180 petajoules) of energy. Although antimatter is sometimes proposed as a source of energy, this does not seem feasible. Artificially producing antimatter – according to current understanding of the laws of physics – involves first converting energy into mass, which yields no net energy.
=== Extra-articular symptoms === Autonomic dysfunction/dysautonomia: Symptoms may include orthostatic intolerance, dizziness, palpitations, Raynaud's phenomenon, and postural orthostatic tachycardia syndrome (POTS). Functional gastrointestinal disorders: Symptoms such as nausea, vomiting, diarrhea, constipation, bloating, early satiety, reflux, and irritable bowel syndrome. Pelvic and bladder dysfunction: Symptoms include pelvic pain, dyspareunia, bladder dysfunction, organ prolapse, and association with conditions like polycystic ovaries, fibroids, or endometriosis. Fatigue: Profound fatigue, often linked to sleep disturbances, non-restorative sleep, and nocturnal musculoskeletal pain, affecting concentration and quality of life. Mood disorders: Anxiety, depression, panic attacks, and emotional distress, often related to chronic pain and reduced physical function. Symptom expression varies widely, with different combinations and severities seen in individuals. Symptoms may fluctuate over time, often triggered by physical exertion, stress, illness, or injury.
== Investigation == Between March and June 2022, unusually high infant mortality rates occurred at a neonatal nursing unit in the Ramón Castillo Neonatal Hospital in Córdoba, Argentina. A series of investigations initially pointed to a hospital-acquired infection or malpractice. The provincial government then intervened at the Ramón Castillo Neonatal Hospital after these reports of healthy babies dying without cause. Prosecutor Raúl Garzón labelled the case as "enormously grave" but initially insisted that they could have been either cases of malpractice or hospital-acquired infections, and no accusations were made. Nonetheless, Garzón ordered a search warrant on the hospital and relieved twenty employees from their duties. Police and prosecutors began to suspect that there had been foul play when no more deaths occurred after the suspension of those twenty employees. On the same day that the hospital was searched, authorities suspended the head of the hospital. The investigation was prompted by a doctor who refused to sign the death certificates of two healthy babies who died on the same day in June 2022; allegedly the two last babies to die from an external cause (murder). As the search warrant was served, the prosecution asked for the exhumation of the remains of the deceased babies, whose autopsies showed abnormal levels of potassium, which medical investigators attributed to being deliberately injected into the babies, as said levels of potassium are not normally produced by the body.
=== Inflammation === Epithelial cells in Sjögren's disease lesions are active participants in the induction and perpetuation of the inflammatory process. Environmental and hormonal factors, in concert with an appropriate genetic background, are believed to trigger Sjögren's disease, which dysregulates epithelial cells and allows aberrant homing and activation of dendritic cells (DCs), T cells, and B cells. Dendritic cells are antigen-presenting cells that process antigen material and present it to other T cells. Following the migration of lymphocytes into the glands in response to chemokines and specific adhesion molecules, T cells interact with epithelial cells. Epithelial cells are further activated by proinflammatory cytokines (IL-1β, IFN-γ, and TNF), which are produced by adjacent T cells. The early accumulation of plasmacytoid dendritic cells in the target tissues, which produce high levels of type 1 IFNs, seems important, as these cells can further dysregulate the immune response through abnormal retention of lymphocytes in the tissues, and their subsequent activation. IFN-α stimulates the production of B-cell activating factor (BAFF) by epithelial cells, DCs, and T cells. BAFF stimulates aberrant B-cell maturation, leading to the emergence of self-reactive B cells, which locally produce autoantibodies, in a germinal centre-like structure (GC-like), which is also the location of lymphomagenesis (origin of lymphoma).
Sources: en.wikipedia.org
In 1824, Chevreul was named director of the dye works at the Gobelins Manufactory in Paris, in response to complaints about technical inadequacies. He found that some dyes were indeed deficient, but that the oft-criticized black dye was first-rate. Yet fabrics dyed with this black were perceived as weak and reddish when surrounded by deep blues and/or purples. Chevreul called this effect simultaneous contrast, defining it as the tendency for a color to appear to shift toward the complementary of its neighbor, both in terms of hue and darkness. He explored the ramifications of the concept at book-length in 1839, intending to form a comprehensive theory for all the visual arts. It offered design principles for tapestries, carpets, furniture, mosaics, churches, museums, apartments, formal gardens, theaters, maps, typography, framing, stained glass, women's clothing, and even military uniforms. It is most noted, however, for its influence on Impressionist and Neo-Impressionist painting, particularly the Pointillist style developed by Georges Seurat and Paul Signac, which featured tiny juxtapositions of complementary colors. Camille Pissarro reported that he had interviewed Seurat, who had described the style as a search for "the modern synthesis with scientifically based means which will be founded on the theory of colors discovered by M. Chevreul and in accordance with the experiments of Maxwell and the measurements of N. O.
=== Similar species === Several species may be confused with A. campestris. The most dangerous confusion may be with the deadly Amanita virosa (a 'destroying angel') or the deadly Amanita hygroscopica (pink-gilled destroying angel). Amanita species may be distinguished from Agaricus by a volva at the base, remnants of a universal veil. Such a veil may also be seen surrounding adjacent smaller button mushrooms, if present. It's recommended to look for smaller sibling buttons nearby, and slice one of them lengthwise to examine their anatomy. They may also be distinguished by a white or off-white spore print while mushrooms in the family Agaricacea are dark brown. In the United States, the poisonous Agaricus californicus and A. hondensis may be similar. White Clitocybe species that also grow in grassy places may be toxic. A less serious, but more common, confusion is with Agaricus xanthodermus (the yellow stainer), which causes gastrointestinal problems in many people. A. arvensis (the horse mushroom) is very similar and is an excellent edible. It is nearly identical (except microscopically) to the edible species Agaricus andrewii and A. solidipes.
==== Alleged and observed psychological disorders ==== Penis panic (koro in Malaysian/Indonesian) — delusion of shrinkage of the penis and retraction into the body. This appears to be culturally conditioned and largely limited to Ghana, Sudan, China, Japan, Southeast Asia, and West Africa. In April 2008, Kinshasa, Democratic Republic of Congo, the West African police arrested 14 suspected victims (of penis snatching) and sorcerers accused of using black magic or witchcraft to steal (make disappear) or shrink men's penises to extort cash for cure, amid a wave of panic. Arrests were made in an effort to avoid bloodshed seen in Ghana a decade before, when 12 penis snatchers were beaten to death by mobs. Penis envy — the contested Freudian belief of all women inherently envying men for having penises.
Pete Wishart, the SNP's longest-serving MP at Westminster, distances himself from the party's election message of making Scotland "Tory-free", describing it as unhelpful. 18 March – Amendments to the Safety of Rwanda (Asylum and Immigration) Bill tabled in the House of Lords are overturned again in the House of Commons. The changes included allowing courts to question Rwanda's safety as a country. Former US president Barack Obama arrives at 10 Downing Street for talks with Sunak. Ofcom finds that five episodes of GB News shows presented by Jacob Rees Mogg, Esther McVey and Phillip Davies broke their rules, and warns the channel about its use of Conservative MPs to host news content. Business Secretary Kemi Badenoch dismisses rumours of a plot to unseat Sunak as Conservative leader as the party continues to fair badly in the polls. 19 March – While speaking to a House of Lords Committee, Chancellor Jeremy Hunt hints that the next general election may take place in October. Labour's Clive Lewis, MP for Norwich South, apologises for swearing in Parliament after he was overheard to use the word "shit" while voting on the government's Rwanda legislation the previous evening. The Football Governance Bill, which aims to establish an independent football regulator for England, is introduced into Parliament. Mark Drakeford attends his final First Minister's Questions as First Minister of Wales.
5-Hydroxyeicosanoid dehydrogenase (5-HEDH) or more formally, nicotinamide adenine dinucleotide phosphate (NADP+)-dependent dehydrogenase, is an enzyme that metabolizes between two eicosanoid metabolites of arachidonate 5-lipoxygenase (5-LOX): 5-hydroxyeicosatetraenoic acid (5-(S)-HETE), and its 5-keto analog 5-oxo-eicosatetraenoic acid (5-oxo-ETE). It also acts in the reverse direction, metabolizing 5-oxo-ETE to 5(S)-HETE. Since 5-oxo-ETE is 30–100-fold more potent than 5(S)-HETE in stimulating various cell types, 5-HEDH is regarded as a regulator and promoter of the influence that 5-LOX and its metabolites have on cell function. Although 5-HEDH has been evaluated in a wide range of intact cells and in crude microsome preparations, it has not yet been evaluated for its structure or gene, and most studies on it have been limited to human tissues.
Sources: en.wikipedia.org
No. Thymosin beta-4 is a 43-residue protein, while TB-500 refers to a seven-residue fragment corresponding to its N-terminal region. The two names are often used loosely in commercial and community writing, which obscures the difference in size, sequence, and likely behavior.
The fragment contains an actin-binding motif, and cell-free experiments show that it can interact with monomeric actin. That observation is the basis for interest in cell migration and repair processes. Effects reported in animals are not established for humans.
Purity is usually stated by the supplier rather than fixed by a pharmacopoeial monograph, and typical listings report a percentage from reverse-phase HPLC. Independent verification is uncommon. Because no single accepted specification exists, comparisons between lots and between suppliers are difficult.
Sealed, desiccated and protected from light, at -20 °C or lower for long-term storage. Short-term storage at refrigerator temperature is common in working laboratories.